Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines.
Kunjachan S, Pola R, Gremse F, Theek B, Ehling J, Moeckel D, Hermanns-Sachweh B, Pechar M, Ulbrich K, Hennink WE, Storm G, Lederle W, Kiessling F, Lammers T.
Kunjachan S, et al. Among authors: ulbrich k.
Nano Lett. 2014 Feb 12;14(2):972-81. doi: 10.1021/nl404391r. Epub 2014 Jan 17.
Nano Lett. 2014.
PMID: 24422585
Free PMC article.